- £12.31bn
- £16.52bn
- £749.00m
- 71
- 18
- 91
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 433 | 432 | 546 | 669 | 749 |
Cost of Revenue | |||||
Gross Profit | 309 | 327 | 406 | 455 | 588 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -498 | -1,058 | -3,931 | 2,363 | 930 |
Operating Profit | 931 | 1,490 | 4,477 | -1,694 | -181 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 902 | 1,464 | 4,355 | -1,967 | -263 |
Provision for Income Taxes | |||||
Net Income After Taxes | 861 | 1,429 | 4,067 | -1,930 | -253 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 858 | 1,427 | 4,060 | -1,927 | -253 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 858 | 1,427 | 4,060 | -1,927 | -253 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.806 | 1.25 | 3.38 | -1.6 | -0.192 |
Dividends per Share |